Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Cmg Pharmaceutical Co., Ltd. (058820:KRX), powered by AI.
Cmg Pharmaceutical Co., Ltd. is currently trading at ₩1,122. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Cmg Pharmaceutical Co., Ltd. on Alpha Lenz.
Cmg Pharmaceutical Co., Ltd.'s P/E ratio is -16.5.
“Cmg Pharmaceutical Co., Ltd. trades at a P/E of -16.5 (undervalued) with modest ROE of -5.2%.”
Ask for details →Cmg Pharmaceutical Co., Ltd. is a company engaged in the development, production, and distribution of pharmaceutical products. Its primary function is to create medical solutions that address various health conditions, contributing to the broader healthcare and life sciences sectors. The company focuses on producing innovative and effective medications that meet high regulatory standards, ensuring safety and efficacy for consumers. Specializing in areas such as biosimilars, generic drugs, and proprietary pharmaceuticals, Cmg Pharmaceutical Co., Ltd. plays a critical role in increasing access to essential medicines and reducing healthcare costs. Its activities support the dynamic pharmaceutical market by advancing medical research and expanding treatment options. Headquartered in South Korea, the company extends its reach through international partnerships, catering to a global clientele. Through its commitment to research and development, Cmg Pharmaceutical Co., Ltd. remains a key player in driving the evolution of healthcare solutions worldwide.
“Cmg Pharmaceutical Co., Ltd. trades at a P/E of -16.5 (undervalued) with modest ROE of -5.2%.”
Ask for details →Cmg Pharmaceutical Co., Ltd. (ticker: 058820) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 229 employees. Market cap is $165.9B.
The current price is ₩1,122 with a P/E ratio of -16.46x and P/B of 0.82x.
ROE is -5.15% and operating margin is -3.51%. Annual revenue is $105.2B.